GE HealthCare TechnologiesSTU:L0T +0.16%68 Days Payable is 95.74 as of Mar. 2026, which is 5% above its 10-year median of 91.05. GuruFocus rates STU:L0T with a GF Score™ of 68/100 and a GF Value™ of €74.60 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 60.96% on this metric.
The historical rank and industry rank for GE HealthCare Technologies's Days Payable or its related term are showing as below:
STU:L0T'
s Days Payable Range Over the Past 10 Years
Min: 75.9 Med: 91.05 Max: 95.2
Current: 90.2
During the past 7 years, GE HealthCare Technologies's highest Days Payable was 95.20. The lowest was 75.90. And the median was 91.05.
STU:L0T's Days Payable is ranked better than 60.96% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs STU:L0T: 90.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:L0T vs DXCM, STE, ZBH: Days Payable Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Days Payable falls into.
GE HealthCare Technologies Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (STU:L0T) has a Days Payable of 95.74 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GE HealthCare Technologies and its competitors. This is near median its historical median of 91.05. Over the past decade, GE HealthCare Technologies' Days Payable has ranged from 75.90 to 95.20. According to the industry distribution chart, GE HealthCare Technologies ranks #310 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is GE HealthCare Technologies' Days Payable too high?
GE HealthCare Technologies' current Days Payable of 95.74 is near median its 10-year median of 91.05. Over the past 10 years, this metric has ranged from a low of 75.90 to a high of 95.20. The Medical Devices & Instruments industry median Days Payable is 67.97. GE HealthCare Technologies' value of 95.74 is 40.9% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #310 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Days Payable compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #310 out of 794 companies for Days Payable. This puts GE HealthCare Technologies in the upper half of its industry. The industry median Days Payable is 67.97. GE HealthCare Technologies' value of 95.74 is 40.9% above this benchmark. Historically, GE HealthCare Technologies' own Days Payable has ranged from 75.90 to 95.20 over the past decade. While the company's 10-year median is 91.05 vs. the industry median of 67.97, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current Days Payable of 95.74 is 40.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current Days Payable is 95.74, which is near median its own 10-year median of 91.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (STU:L0T) is currently considered Modestly Undervalued. The stock's GF Value™ is €74.60, compared to a current price of €56.82 — trading 23.8% below its estimated fair value. The current Days Payable is 95.74, which is near median its 10-year median of 91.05 and 40.9% above the Medical Devices & Instruments industry median of 67.97. GE HealthCare Technologies' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For GE HealthCare Technologies (STU:L0T), the current Days Payable is 95.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (STU:L0T) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of €56.82 is trading 23.8% below its estimated GF Value™ of €74.60.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for STU:L0T:
Days Payable: 95.74 (near median its 10-year median of 91.05)
GF Value™: €74.60 vs. price of €56.82 (23.8% below fair value)
Industry Position: 40.9% above the Medical Devices & Instruments median (#310 of 794)
No single metric tells the full story. See the STU:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
68GF Score
Get the complete analysis for STU:L0T
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L0T has been successfully added to your 
